Induction of lymphokine-activated killer cells of equine origin: specificity for equine target cells
- 30 April 1992
- journal article
- research article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 32 (1-2) , 25-36
- https://doi.org/10.1016/0165-2427(92)90066-y
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Role of CD18 in lymphokine, activated killer (LAK) cell‐mediated lysis of human monocytes: Comparison with other lak targetsInternational Journal of Cancer, 1990
- Bovine natural cell mediated cytotoxicity (NCMC): Activation by cytokinesVeterinary Immunology and Immunopathology, 1990
- Natural cytotoxicity in the dog: Description of two new allogeneic tumour targetsVeterinary Immunology and Immunopathology, 1989
- Tumoricidal effect of interleukin-2-activated killer cells in caninesVeterinary Immunology and Immunopathology, 1989
- T Lymphocyte Development in Horses I. Characterization of Monoclonal Antibodies Identifying Three Stages of T Lymphocyte DifferentiationVeterinary Immunology and Immunopathology, 1988
- The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative ActivitiesScience, 1987
- Induction of IL-2 and lymphokine activated killer cells in the catVeterinary Immunology and Immunopathology, 1987
- Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated LymphocytesAnnual Review of Immunology, 1986
- Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.The Journal of Experimental Medicine, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982